Is This the HIV Prevention Pill We’ve Been Waiting For?
In a cautious yet necessary step forward, The U.S. Food and Drug Administration (FDA) said the “Truvada” pill is safe for HIV prevention.
We told you last year about clinical trials of an HIV vaccine in Canada, though this would be the first pill of its kind.
Now, before you go throwing out your stash of condoms, there are still the risks — and the pricetag — of the medication.
A year’s supply of this pill, manufactured by California-based Gilead, rings up at about $11,000. Depending on where you shop and clubs you dance at, a year’s supply of condoms could be free. Just sayin’.
Not only that, but there is a high risk for “renal toxicity” associated with taking Truvada. These factors along with others like education and “prescribed uses” will come up at the May 10 advisory committee meeting later this week.The scientifically inclined can read the initial FDA report here.
For those Unicorns getting the Booty, you’re considered “at risk” for HIV if you’re one of the “275,000 gay men who had more than two partners in the past year and didn’t wear condoms during sex.”
Remember, no love without the glove. For now.
What do you think about the chance of preventative medication?